Voyager Therapeutics Stock Investor Sentiment
| VYGR Stock | USD 3.88 0.21 5.13% |
Slightly above 56% of Voyager Therapeutics' investor base is looking to short. The analysis of the overall investor sentiment regarding Voyager Therapeutics suggests that many traders are alarmed. Voyager Therapeutics' investing sentiment overview a quick insight into current market opportunities from investing in Voyager Therapeutics. Many technical investors use Voyager Therapeutics stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Comfort Level 44
Impartial
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Voyager Therapeutics' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Voyager Therapeutics.
News SentimentBullish | Hype SentimentBearish | Insider SentimentDisposing |
Voyager Historical Sentiment
Although Voyager Therapeutics' investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Voyager, such as negative comments on social media and news outlets, may cause fear in the market and push Voyager Therapeutics' investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Voyager.
Voyager |
Voyager Therapeutics Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Voyager Therapeutics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Far too much social signal, news, headlines, and media speculation about Voyager Therapeutics that are available to investors today. That information is available publicly through Voyager media outlets and privately through word of mouth or via Voyager internal channels. However, regardless of the origin, that massive amount of Voyager data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Voyager Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Voyager Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Voyager Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Voyager Therapeutics alpha.
Voyager Therapeutics Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | Disposition of 6500 shares by Robin Swartz of Voyager Therapeutics at 5.65 subject to Rule 16b-3 | 12/23/2024 |
2 | Disposition of 1191 shares by Todd Carter of Voyager Therapeutics at 5.13 subject to Rule 16b-3 | 01/14/2025 |
3 | Is it a Good Idea to Invest in Stoke Therapeutics Stock Now - Yahoo Finance | 01/17/2025 |
4 | Disposition of 5000 shares by Todd Carter of Voyager Therapeutics at 2.85 subject to Rule 16b-3 | 01/24/2025 |
5 | Disposition of 4358 shares by Fahey Sandell Jacquelyn of Voyager Therapeutics at 4.45 subject to Rule 16b-3 | 02/11/2025 |
6 | Kirby McInerney LLP Announces Investigation Against Voyager Therapeutics, Inc. ... | 02/19/2025 |
7 | Acquisition by Jorgensen Nathan D. of 103000 shares of Voyager Therapeutics at 4.22 subject to Rule 16b-3 | 02/21/2025 |
8 | VOYAGER ALERT Bragar Eagel Squire, P.C. is Investigating Voyager Therapeutics, Inc. ... | 02/25/2025 |
9 | Voyager Reports Positive Topline Data for Single Ascending Dose Trial of Anti-Tau ... | 03/03/2025 |
10 | Voyager Therapeutics Announces Fourth Quarter 2024 Conference Call and Webcast | 03/04/2025 |
11 | CytomX Therapeutics Tops Q4 Earnings and Revenue Estimates | 03/06/2025 |
12 | Acquisition by Todd Carter of 5000 shares of Voyager Therapeutics at 2.85 subject to Rule 16b-3 | 03/11/2025 |
13 | Q4 2024 Voyager Therapeutics Inc Earnings Call Transcript | 03/12/2025 |
14 | Acquisition by Sandrock Alfred of 145000 shares of Voyager Therapeutics subject to Rule 16b-3 | 03/13/2025 |
15 | Q1 EPS Estimates for Voyager Therapeutics Lowered by Wedbush | 03/19/2025 |
Additional Tools for Voyager Stock Analysis
When running Voyager Therapeutics' price analysis, check to measure Voyager Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Voyager Therapeutics is operating at the current time. Most of Voyager Therapeutics' value examination focuses on studying past and present price action to predict the probability of Voyager Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Voyager Therapeutics' price. Additionally, you may evaluate how the addition of Voyager Therapeutics to your portfolios can decrease your overall portfolio volatility.